CBD/Hemp Oil Extract PLUS PEA (Palmitoylethanolamide) For Pain & Inflammation This Study
PEA is not addictive, not psycho-active and will NOT get you high. In a large percentage of cases it WILL assist with chronic inflammation and pain. (You can read all about the pain research at our Australian Chemist Site - where you can order in person, online or by phone.)
Palmitoylethanolamide capsules and skin creams do NOT require a prescription. This valuable supplement is found naturally in our bodies, and because of this is non-toxic. You cannot overdose, and PEA does not interact with your medicines. Small amounts are found in milk (especially mother's milk) and eggs.
PEA has been researched for many different conditions around the world, here are some of the most common: (TGA rules say that No claims can be made in Australia about effectiveness for any condition. This is just a list of areas where research is happening.)
More Information on the research and dosages for these conditions:

Pain Specialists all around the world are now recommending palmitoylethanolamide as either capsules or skin creams. Many health professionals recommend PEA as a health supplement for people having medical treatments.
Highest quality supplements prepared by pharmacists in Australia.
The right sized capsule for best convenience - 4 caps per day each 300mg.
Recommended increasingly by natural health practitioners and wholistic doctors.

Palmitoylethanolamide is Available from SCHC Pharmacy.
You can order by:

CBD/Hemp Oil Extract PLUS PEA (Palmitoylethanolamide) For Pain & Inflammation This Study
Palmitoylethanolamide for Knee Osteoarthritis Study. Significant Reductions In Pain & Stiffness Score.
Romance Is Easier When Everything Does Not Hurt… Palmitoylethanolamide has been shown
Positive Research News for AWS with Endocannabinoid Palmitoylethanolamide Supplement Here are the
This Australia Day Weekend, help yourself. $10 off PEA 120 capsule bottles
Studies Related to Palmitoylethanolamide and Dental Pain ” Br J Clin Pharmacol.
Copyright 2018-20, Palmitoylethanolamide - Disclaimer